AARTIDRUGS trade ideas
Aarti Drugs - Key Levels to WatchAarti Drugs - Key Levels to Watch 🔍
Aarti Drugs has shown some recovery after restoring production at its Tarapur unit, as per recent filings. Here’s the technical outlook:
1.Fibonacci Retracement Levels:
Resistance at 0.618 (₹593) and 0.5 (₹676).
Immediate support near 0.786 (₹476).
2.Volume Profile:
High activity seen between ₹450-₹500. Sustained support in this zone is crucial.
3.RSI:
Current RSI shows a slight bullish divergence—monitor for a potential rebound.
Levels of Interest:
Upside Potential: ₹593 (618 Fib) and ₹676 (0.5 Fib).
Downside Support: ₹476 (786 Fib) and ₹450 (volume support zone).
Stay cautious as the stock consolidates. Monitor for clear directional moves above or below these levels.
Aarti drug breakout structureAarti drug can double from here with in few years. Sl below the trend line.
Chart is self explanatory. Please follow the price action & take the trade as per your appetite.
The information provided here is only for educational purpose. The information provided here is not intended to be any kind of financial advice, investment advice, and trading advice. Investment in stock market is very risky and trading stocks, options and other securities involve risk. The risk of loss in stock market can be substantial. Moreover, I am not a SEBI registered analyst, so before taking any decision or before investing in any Share consult your financial advisor and also do your analysis and research.
Request your support and engagement by liking and commenting & follow to provide encouragement.
Aarti Drugs Bullish, Kindly do your own studyThis stock is looking bullish. Please do your study before taking any decision.
Monthly price is above 50 EMA and also above 5 EMA
After big rally ABC correction seems to be over
New impulse could be started. 1st wave has been completed and in 2nd wave also ABC seems to be over
Monthly MACD PCO above zero line
Weekly MACD PCO
Weekly RSI is above 50
Weekly price is above 50 EMA and golden crossover is happening
Daily price has given breakout
Daily RSI is above 60
Daily ADX
Volume is above average
Aarti Drugs giving signs of pennant Breakout. Aarti Drugs Limited (ADL) is a prominent manufacturer of APIs, Pharma Intermediates, and Specialty Chemicals. ADL engages in the development, manufacture and market of pharmaceutical products. The firm operates through the Out of India, and India geographical segments.
Aarti Drugs Limited (ADL) CMP is 495.70. The positive aspects of the company are Company with Low Debt, Growth in Quarterly Net Profit with increasing Profit Margin, Company with Zero Promoter Pledge, FII / FPI or Institutions increasing their shareholding, and Mutual Funds Increased Shareholding. The Negative aspects of the company are Decline in Quarterly Net Profit, MFs decreased their shareholding last quarter and Promoter decreasing their shareholding.
Entry can be taken after closing above 503 Targets in the stock will be 519 and 531. The long-term target in the stock will be 549 and 568. Stop loss in the stock should be maintained at Closing below 456.
The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
Wave 3 in AARTIDRUGS can push price up by 80%!!The Stock witnessed a five-wave impulsive rise beginning in March 2023 and ending in July 2023.
The impulse move led to a 105% rally in the stock in a matter of just 5 months.
Since the completion of the wave 1 in July however, the stock went into the corrective wave 2 structure between July-October. The corrective phase can be marked as an Elliot wave Zig-zag(ABC) and led to a 50% retracement of the wave 1.
This phase ended in October and between October-November the stock displayed a slow moving leading diagonal as the first sign of reversal from the bottom of INR 444.This tiny diagonal is the only starting piece of the massive leg that is yet to unfold in the stock, taking it towards the INR 900 mark. The diagonal and its correction can be labeled as wave i&ii of 3 respectively and
now the stock has "jump-started" the wave iii of 3 on 18DEC with a +4.2% closing alongside uptick in volumes.
Upon successfully surpassing INR500 level, the stock shall be at the INR550 in 'very quick move'.
INR 900 is the projected target region for the Wave 3.
On the downside INR 470 can be used as 'SL'.
Note*- The views expressed are based on personal opinions and observations. Please do your own research before making any trading/investing decisions.
Resistance Breakout
Please look into the chart for a detailed understanding.
Consider these for short-term & swing trades with 2% profit.
For BTST trades consider booking
target for 1% - 2%
For long-term trades look out for resistance drawn above closing.
Please consider these ideas for educational purpose
Aarti Drugs looking to dazzleAarti drugs limited is a pharmaceutical & biotechnology company engaged in manufacturing of APIs (Active Pharmaceutical Ingredients), Pharma Intermediates & Specialty chemicals. With strong Research and Development (R&D) and GMP certified manufacturing units the company aims to provide quality and effective solutions to their clients PAN India.
CMP of the stock is 457.80. Negative of the company is declining annual net profit. Positives of the company are low debt, improving quarterly net profit and FIIs and MFs are increasing stake.
Entry in the stock can be taken after closing above 471. Target will be 512 & 531. Long term target will be 600+. Stop loss in the stock should be kept at the closing below 396.